Cost-effectiveness of different diagnostic tests for the study of benign prostatic hyperplasia
Arlandis Guzmán, S.; Jiménez Cruz, F.
Revista Clinica Espanola 199(Suppl 2): 36-43
1999
ISSN/ISBN: 0014-2565 PMID: 10887545 Document Number: 506527
Document emailed within 1 workday
Related Documents
McClennan, B.L. 1990: Diagnostic imaging evaluation of benign prostatic hyperplasia Urologic Clinics of North America 17(3): 517-536Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Zhiborev, A.B.; Martov, A.G. 2018: The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia Urologiia 4: 81-87
Ding, M.; Nian, Y.-q.; Hu, S.-b.; Yi, L.; Chen, F.-z.; Peng, M.; Wang, Y.-h. 2015: Safety and effectiveness of GreenLight 120-W laser photoselective vaporization of the prostate for benign prostatic hyperplasia: a meta-analysis Zhonghua Nan Ke Xue 21(7): 646-654
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Liang, Y.-y.; Cao, M.-x.; Dai, Y.-p.; Liang, W.-j.; Zheng, K.-l. 2006: Diagnostic value of urodynamic parameters multianalysis in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia Zhonghua Nan Ke Xue 12(9): 818-821
Song, Y.; Li, N.-c.; Wang, X.-f.; Ma, L.-l.; Wan, B.; Hong, B.-f.; Na, Y.-q. 2005: Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia Zhonghua Nan Ke Xue 11(9): 674-676
Yajima, M.; Takemura, H.; Nishida, S.; Matsushita, T.; Yanagisawa, N.; Baba, K.; Iwamoto, T. 1999: Clinical study of transurethral electrovaporization of the prostate for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 45(9): 609-612
Guo, X-Kun.; Bian, J.; Nie, Y.; Zhang, Z-Xiang.; Li, W-Li.; Zhang, Y.; Gao, W-Yang.; Feng, Y-Ju.; Cheng, S-Ping.; Xiang, Y-Jiu. 2003: Experimental study of vasoligation in the treatment and prevention of benign prostatic hyperplasia Zhonghua Nan Ke Xue 9(1): 20-23
Armenian, H.K.; Lilienfeld, A.M.; Diamond, E.L.; Bross, I.D. 1974: Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study Lancet 2(7873): 115-117
Anwarul Islam, A.K.M.; Kashem, M.A.; Shameem, I.A.; Kibria, S.A.M.G. 2005: Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: a comparative study Bangladesh Medical Research Council Bulletin 31(2): 54-61
English, E.C.; Geyman, J.P. 1978: The efficiency and cost effectiveness of diagnostic tests for infectious mononucleosis Journal of Family Practice 6(5): 977-981
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Tveter, K.J.; Beisland, H.O.; Andersen, J.T.; Wolf, H.; Ekman, P.; Johansson, J.E.; Kontturi, M.; Lehtonen, T. 1996: Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(27): 3226-3230